Maikel L. Colli
Mechelen-bovelingen, VLG 2800, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Inhibition of Salt-Inducible Kinases 2 and 3 reduces inflammatory signature in Psoriasis.
Journal: The Journal of investigative dermatology
Published: January 14, 2026
Pharmacological Characterization of GLPG3667, a Tyrosine Kinase 2-Selective Inhibitor, for the Treatment of Inflammatory and Autoimmune Diseases.
Journal: Inflammation
Published: December 24, 2025
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes.
Journal: JCI insight
Published: July 03, 2025
Identification of novel type 1 and type 2 diabetes genes by co-localization of human islet eQTL and GWAS variants with colocRedRibbon.
Journal: Cell genomics
Published: December 12, 2024
Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells.
Journal: bioRxiv : the preprint server for biology
Published: September 25, 2023
Interferon-α promotes HLA-B-restricted presentation of conventional and alternative antigens in human pancreatic β-cells.
Journal: Nature communications
Published: September 15, 2023
ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation.
Journal: Frontiers in endocrinology
Published: September 30, 2022
Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic β cells.
Journal: Science advances
Published: September 14, 2022
Pro-Inflammatory Cytokines Promote the Transcription of Circular RNAs in Human Pancreatic β Cells.
Journal: Non-coding RNA
Published: August 25, 2022
A Humanized Mouse Strain That Develops Spontaneously Immune-Mediated Diabetes.
Journal: Frontiers in immunology
Published: July 28, 2021
Last Updated: 09/26/2026